Leader in AI powered Drug Development and Precision Medicine
Superior Science and Risk-Sharing Business Models
DYNAMIKA, Cloud AI-Powered Platform for Data Management
Smart Imaging Strategy to Accelerate Drug Development
Why embracing digital transformation in drug development is the Leader’s’ job.
IAG, Image Analysis Group
IAG brings radiological expertise and artificial intelligence in a meaningful way to imaging processes, accelerating the power and speed of critical decision making within clinical drug development.
DYNAMIKA, IAG’s Cloud Platform
IAG’s proprietary platform DYNAMIKA supports seamless data collection, real-time image Quality Control, analytics, and data ingestion. DYNAMIKA brings AI / ML into trial process to allow for a fully transparent data management, trial execution control and central review. ISO Certified, GCP, HIPAA, FDA, 21 CFR part 11
Global Client Services: Clinical Trials
IAG’s project, site support and data teams are located in the USA, UK, EU and Asia. We strategically use radiology imaging, AI and technology to accelerate drug development and lower investment risks. Whether you are entering a phase I/II and need early robust efficacy data or preparing a global phase 3 trial, our science, operations and technology teams will work with you to develop the right solution.
Since 2007, over 2000 articles were published to cover scientific discoveries, technology break-throughs and special cases. We list here some critically important papers and abstracts.